Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
May 09, 2024
CGD NOTES
May 07, 2024
WORKING PAPERS
April 23, 2024
WORKING PAPERS
May 01, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
POLICY PAPERS
December 11, 2023
Factors like borrowing costs and access to alternative sources of finance will likely limit country demand for World Bank climate mitigation finance absent financial incentives, which could prove costly and difficult to resource at the scale needed to have meaningful impact. There's a risk that thes...
POLICY PAPERS
October 12, 2023
The Multilateral Investment Guarantee Agency (MIGA), which offers investors and bankers political risk insurance and guarantees against non-payment by governments and state-owned enterprises, should feature heavily in the private sector reform agenda. We offer recommendations that would enable MIGA ...
BRIEFS
July 17, 2023
In the fall of 2022, World Bank shareholders (member governments, including the United States) called for a suite of reforms aimed at better enabling the institution to respond to today’s global development challenges, such as pandemics, climate change, and natural disasters. The World Bank is one o...
WORKING PAPERS
January 25, 2016
Many developing countries need the World Bank’s capital less and less. What role should the Bank play in the 21st century? This paper argues that many features of the Bank today reflect a new role. That role, resting on the economic theory of bargaining and public good provision, is to reduce ...
ESSAYS
January 19, 2016
If Africa’s smallholder farmers are going to lift themselves out of poverty, they need access to formal financial services instead of the unstable, inflexible, informal arrangements that they currently rely on and that keep them poor. Ngozi Okonjo-Iweala and Janeen Madan review the ways in whi...
WORKING PAPERS
July 15, 2013
We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer’s ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, reven...